Rosemont Pharmaceuticals
Vicki Sharp (Blount) is the Head of Research and Development at Rosemont Pharmaceuticals, responsible for strategic direction and management of various departments. She previously held roles as Head of Formulation Sciences and Scientific Services at Reckitt, Head of Operations for Science, Sensory and Clinical at Synergy, and Development Services Manager at Boots Contract Manufacturing. Vicki is experienced in defining and implementing global functional strategies and ensuring key performance indicators are met in various research and development services. She is a Bachelor of Science graduate in Chemistry from Nottingham Trent University.
This person is not in any offices
Rosemont Pharmaceuticals
At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.